Working with health ministries, regulatory authorities, professional societies, universities and industry leaders across every continent to advance pathology practice, education and workforce development.
Our flagship partnership supporting Saudi Vision 2030 healthcare transformation. Collaboration spans digital pathology implementation across 47 MOH hospitals, AI-assisted diagnostics pilot programmes, national pathology workforce planning and development of the Saudi Digital Pathology Roadmap 2026–2030.
Joint development of pathology training standards, Saudi Board examination content review, CPD accreditation framework for digital pathology courses, and international credential equivalency guidelines. Co-development of the SCFHS Digital Pathology Competency Framework.
Supporting UAE’s National Strategy for AI 2031 in healthcare. Collaboration includes AI-powered laboratory quality assurance, Emirates Health Services digital transformation, cross-emirate telepathology network development and joint research on population-specific cancer biomarkers.
Collaboration on Dubai’s Smart Health Strategy, digital pathology licensing framework for AI-based diagnostic tools, and joint workforce forecasting for laboratory medicine professionals in the emirate.
Partnership supporting Qatar National Health Strategy 2023–2030. Joint initiatives include the Qatar National Pathology Quality Improvement Programme, integration of AI-assisted cancer screening at Hamad Medical Corporation, and development of national laboratory accreditation standards aligned with ISO 15189.
Collaboration on laboratory modernization across Kuwait’s public hospital network, joint continuing education programmes for Kuwaiti pathologists, and advisory role on Kuwait’s National Cancer Registry digital infrastructure.
Joint digital pathology training programme at Salmaniya Medical Complex, advisory role on Bahrain’s telepathology pilot connecting primary health centres to specialized diagnostics.
Partnership on Oman Vision 2040 healthcare goals. Joint laboratory quality assessment programme and advisory support for the development of the Oman National Reference Laboratory.
Long-standing partnership supporting NHS digital pathology transformation. Collaboration with NHS England on the National Pathology Imaging Co-operative (NPIC), Health Education England on pathology workforce strategy, and NHSX on AI regulatory frameworks for diagnostic devices. Joint research on the economic impact of digital pathology adoption across NHS trusts.
Partnership on Germany’s Digital Health Applications Act (DiGA) as it applies to AI-based pathology diagnostics. Collaboration with the Federal Institute for Drugs and Medical Devices (BfArM) on regulatory pathways, and joint research on digital pathology integration within the German university hospital system.
Collaboration on the Dutch national digital pathology infrastructure programme and joint research with UMC Utrecht and Radboud UMC on computational pathology deployment.
Partnership with the HAS (Haute Autorité de Santé) on evaluation frameworks for AI-based in vitro diagnostics. Joint programmes with AP-HP and Institut Gustave Roussy on digital pathology research.
Collaboration with the Karolinska Institute and Swedish eHealth Agency on national whole-slide imaging standards and joint AI validation studies for cervical screening programmes.
Joint research with ETH Zürich and University of Bern on federated learning for pathology AI models. Advisory role on Swiss regulations for software as a medical device (SaMD) in diagnostics.
Partnership with the HSE on Ireland’s National Histopathology Quality Improvement Programme and digital pathology rollout across voluntary and HSE hospitals.
Collaboration on Spain’s Digital Health Strategy 2025–2030 for pathology services. Joint initiatives with Hospital Clínic Barcelona and Hospital Vall d’Hebron on AI-integrated cancer diagnostics.
Partnership with the Istituto Superiore di Sanità on laboratory quality standards and AI-based diagnostic pathways. Joint training programmes with University of Turin and Humanitas Research Hospital.
Advisory partnership on Poland’s national telepathology network connecting regional hospitals to university-based specialist pathologists. Joint CPD programmes with the Medical University of Warsaw.
Additional European partners include health ministries of Denmark, Norway, Finland and Austria, with collaboration focused on Nordic digital pathology networks, EU AI Act implementation and cross-border laboratory quality harmonization.
Partnership supporting India’s Ayushman Bharat Digital Mission. Joint initiatives on AI-assisted cytology screening for cervical cancer in rural India with AIIMS and Tata Memorial Hospital. Collaboration on national telepathology guidelines and digital health interoperability standards.
Collaboration with PMDA on regulatory science for AI-based pathology devices. Joint digital pathology research with the University of Tokyo and National Cancer Center Japan. Partnership on Japan’s Society 5.0 healthcare innovation agenda.
Joint initiatives with HSA and SingHealth on AI regulatory sandbox for pathology diagnostics. Research collaboration with the National University of Singapore on multimodal pathology AI and federated learning across ASEAN hospital networks.
Partnership on Korea’s Digital New Deal healthcare pillar. Joint research with Seoul National University Hospital and Samsung Medical Center on AI-powered cancer grading systems and digital pathology adoption metrics.
Collaboration with the TGA on regulatory pathways for AI-based pathology software, and joint rural telepathology initiatives with the Royal College of Pathologists of Australasia (RCPA) to improve diagnostic access in remote communities.
Partnership on Health New Zealand’s laboratory services digitization programme. Joint advisory on equitable pathology access for Māori and Pacific communities through telepathology and AI-assisted screening.
Collaboration through FDA’s Digital Health Center of Excellence on regulatory pathways for AI/ML-based pathology software. Joint research with NIH National Cancer Institute on AI-driven cancer biomarker discovery. Advisory input on CMS reimbursement frameworks for digital pathology services.
Partnership on Canada’s Pan-Canadian Health Data Strategy as it applies to digital pathology. Joint initiatives with the Canadian Association of Pathologists and University Health Network Toronto on AI validation methodologies.
Collaboration on ANVISA regulatory framework for AI diagnostics and joint telepathology pilot connecting SUS (Unified Health System) facilities in the Amazon region to specialist pathologists in São Paulo and Rio de Janeiro.
Advisory partnership on laboratory quality improvement across Argentina’s national hospital system and joint training programme with the University of Buenos Aires School of Medicine on digital pathology fundamentals.
Partnership on the National Health Insurance (NHI) laboratory strategy. Joint AI-assisted cervical cancer screening programme with the National Health Laboratory Service (NHLS) and University of Cape Town. Research on deploying digital pathology in resource-limited settings across sub-Saharan Africa.
Collaboration on Egypt’s Digital Egypt initiative for healthcare. Joint laboratory modernization programme with the National Cancer Institute Cairo and training for Egyptian pathologists on AI-assisted diagnostics through the Egyptian Medical Syndicate.
Partnership on Nigeria’s National Cancer Control Plan laboratory infrastructure. Joint telepathology pilot connecting secondary hospitals to specialist pathologists at Lagos University Teaching Hospital and University College Hospital Ibadan.
Advisory partnership on Kenya’s Universal Health Coverage pathology strategy. Joint training programmes with the University of Nairobi and Aga Khan University Hospital on digital pathology fundamentals for East African pathologists.
Additional African engagement: exploratory discussions with health ministries of Morocco, Ghana, Tanzania and Rwanda on digital pathology capacity building and cross-border telepathology networks for sub-Saharan Africa.
Contributing partner on WHO guidelines for digital diagnostics in low- and middle-income countries. Joint publications on essential diagnostics list updates for pathology services. Advisory input on AI governance frameworks for health technologies.
Strategic partnership on global pathology education, joint conference programming, digital pathology curriculum development and coordinated advocacy for pathology workforce investment worldwide.
Joint conference programming at the European Congress of Pathology, collaborative guidelines on digital pathology quality assurance, and shared educational resources for European pathology trainees.
Collaboration on laboratory medicine harmonization, joint publications on quality indicators for clinical laboratories, and shared digital transformation best practices for laboratory services worldwide.
Additional international partners include the College of American Pathologists (CAP), Royal College of Pathologists (RCPath), Digital Pathology Association (DPA) and the International Society of Digital Pathology (ISDP).
First health ministry collaboration established, focused on NHS digital pathology transformation and workforce planning.
Strategic partnerships with Saudi Arabia’s Ministry of Health and the International Academy of Pathology launched. Vision 2030 collaboration begins.
Partnerships with Germany BMG, UAE MOHAP, SCFHS, WHO, ESP and FDA Digital Health Center of Excellence established. Six new MoUs signed.
Health ministry partnerships in India, Qatar and South Africa established. First AI pilot projects launched with partner institutions.
Japan MHLW, Singapore MOH, South Korea MOHW and Health Canada partnerships formalized. IFCC collaboration begins.
Partnerships with Kuwait, Bahrain, Oman, Switzerland, Australia, Ireland and Egypt established. 50th partner organization milestone reached.
Brazil, Spain, Italy, Nigeria and New Zealand partnerships launched. First cross-border telepathology project deployed.
Argentina, Kenya and Poland partnerships established. 68 partner organizations across 42 countries. 15 active MoUs.
Active engagement with health ministries of Morocco, Ghana, Tanzania, Rwanda, Denmark, Norway, Finland and Austria. Target: 80 partners across 50 countries by year-end.
We welcome partnerships with health ministries, regulatory bodies, professional societies, universities, hospitals and technology companies committed to advancing pathology practice worldwide.
Collaborate on national pathology strategies, digital transformation, workforce planning, AI regulatory frameworks and laboratory quality improvement programmes.
EnquireJoint conference programming, shared educational resources, collaborative guidelines development, CPD accreditation and advocacy for pathology investment.
EnquireResearch collaboration, fellowship exchanges, joint publications, clinical validation studies and digital pathology implementation support.
Enquire68 partner organizations across 42 countries, working together to advance pathology practice, education and innovation. Join our growing network of health ministries, professional societies and institutions.